Abuse-Deterrent Opioids

New England CEPAC

ICER will develop a report reviewing the clinical effectiveness and value of abuse-deterrent opioids. The report will be the subject of a July 20, 2017 meeting of the New England CEPAC.

Key Dates

Associated Materials

09/08/2016

ICER’s Draft Scoping Document for a review of abuse-deterrent opioid formulations. This scoping document was open to public comment for three weeks.


09/08/2016

09/08/2016 – 09/28/2016

Public Comment on Draft Scoping Document.

Public Comments On Draft Scoping Document

10/13/2016

11/08/2016

01/24/2017

05/05/2017

05/05/2017

06/28/2017

06/28/2017

06/28/2017

06/28/2017

07/20/2017

Public Meeting of the New England CEPAC.


07/20/2017

08/04/2017
Final Evidence Report and Meeting Summary